下一代定序服务市场－全球产业规模、份额、趋势、机会和预测（按服务、工作流程、最终用户、地区和竞争细分，2020-2030 年）

2024年，全球次世代定序 (NGS) 服务市场规模达59.7亿美元，预计2030年将达到205.9亿美元，预测期内复合年增长率为22.92%。推动这一增长的因素包括基因组技术的快速发展、精准医疗需求的不断增长、NGS在临床研究中的应用不断拓展以及遗传疾病患病率的不断上升。技术进步带来了速度更快、成本效益更高的定序平台，使研究人员和临床医生更容易使用NGS。基于基因图谱的个人化治疗方法日益受到关注，以及NGS在诊断和临床试验中的应用日益广泛，这进一步刺激了医疗保健和生命科学领域的需求。

关键市场驱动因素

个人化医疗需求不断成长

主要市场挑战

高成本和基础设施需求

主要市场趋势

人工智慧在NGS数据分析中的整合

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球次世代定序服务市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 依服务分类（人类基因组定序服务、单细胞定序服务、微生物基因组定序服务、基因调控服务、其他）
  • 依工作流程（预测序、定序、数据分析）
  • 按最终用户（医院和诊所、学术和研究机构、製药和生物技术公司、其他）
  • 按地区
  • 按公司分类（2024）
• 产品图
  • 按服务
  • 按工作流程
  • 按最终用户
  • 按地区

第六章：北美次世代定序服务市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲次世代定序服务市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太下一代定序服务市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：南美下一代定序服务市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第十章：中东与非洲次世代定序服务市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 近期发展
• 併购
• 产品发布

第十三章：全球次世代定序服务市场：SWOT分析

第 14 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 15 章：竞争格局

• Quest Diagnostics Inc.
• Applied Biological Materials, Inc.
• Novogene Co, Ltd.
• Azenta Life Sciences (GENEWIZ)
• NanoString Technologies, Inc.
• Illumina, Inc.
• PacBio, Inc.
• Gene by Gene Ltd
• Lucigen Corporation
• ARUP Laboratories

第 16 章：策略建议

第17章调查会社について・免责事项

The Global Next Generation Sequencing (NGS) Services Market was valued at USD 5.97 billion in 2024 and is projected to reach USD 20.59 billion by 2030, growing at a CAGR of 22.92% during the forecast period. This growth is driven by rapid advancements in genomic technologies, rising demand for precision medicine, expanding applications of NGS in clinical research, and the increasing prevalence of genetic disorders. Technological improvements have led to faster and more cost-effective sequencing platforms, making NGS more accessible to researchers and clinicians. The growing focus on personalized treatment approaches based on genetic profiling and the integration of NGS in diagnostics and clinical trials are further boosting demand across healthcare and life science sectors.

Key Market Drivers

Rising Demand for Personalized Medicine

The rising interest in personalized medicine is a major catalyst for the expansion of the NGS services market. Personalized medicine leverages genetic data to tailor medical care to individual patients, improving treatment effectiveness and disease management. NGS facilitates in-depth genomic analysis, helping identify mutations that influence disease risk and therapeutic responses.

Governments around the world are actively supporting this shift through large-scale initiatives. For instance, the U.S. National Institutes of Health's All of Us Research Program and the European Union's Horizon 2020 initiative have allocated substantial funding toward genomics research to promote personalized healthcare. These efforts underscore the central role of NGS in the evolving landscape of precision medicine.

Key Market Challenges

High Costs and Infrastructure Requirements

Despite the reduction in sequencing costs per genome, the overall financial burden of establishing and running NGS operations remains substantial. Setting up NGS laboratories demands significant investments in high-end equipment, computational systems, and trained personnel. Additionally, recurring costs for consumables, system maintenance, and data storage present ongoing challenges, particularly for facilities in developing nations.

The complexity of NGS workflows also requires continuous training and expertise, adding to operational overheads. These financial and technical barriers hinder the broader integration of NGS in low-resource settings. Although global programs-such as the Africa Pathogen Genomics Initiative-are working to expand infrastructure, disparities in access to NGS services persist.

Key Market Trends

Integration of Artificial Intelligence in NGS Data Analysis

The adoption of artificial intelligence (AI) and machine learning (ML) is emerging as a transformative trend in NGS services. Given the vast and complex nature of sequencing data, AI tools are increasingly essential for extracting meaningful insights. These technologies enhance pattern recognition, data interpretation, and predictive modeling in both clinical and research contexts.

In healthcare, AI-driven analysis supports accurate genetic diagnoses by identifying disease-associated variants and forecasting treatment responses. In research, AI facilitates discovery of novel biomarkers and therapeutic targets. Government-backed programs, such as those led by the U.S. NIH, are investing in AI-genomics integration, recognizing its potential to accelerate progress in personalized medicine and genomics-based research.

Key Market Players

• Quest Diagnostics Inc.
• Applied Biological Materials, Inc.
• Novogene Co, Ltd.
• Azenta Life Sciences (GENEWIZ)
• NanoString Technologies, Inc.
• Illumina, Inc.
• PacBio, Inc.
• Gene by Gene Ltd
• Lucigen Corporation
• ARUP Laboratories

Report Scope:

In this report, the Global Next Generation Sequencing Services Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Next Generation Sequencing Services Market, By Service:

• Human Genome Sequencing Services
• Single Cell Sequencing Services
• Microbial Genome-based Sequencing Services
• Gene Regulation Services
• Others

Next Generation Sequencing Services Market, By Workflow:

• Pre-Sequencing
• Sequencing
• Data Analysis

Next Generation Sequencing Services Market, By End User:

• Hospitals & Clinics
• Academic & Research Institutions
• Pharmaceutical & Biotechnology Companies
• Others

Next Generation Sequencing Services Market, By Region:

• North America
  • United States
  • Mexico
  • Canada
• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
• Asia-Pacific
  • China
  • India
  • South Korea
  • Japan
  • Australia
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Next Generation Sequencing Services Market.

Available Customizations:

Global Next Generation Sequencing Services Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Next Generation Sequencing Services Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Service (Human Genome Sequencing Services, Single Cell Sequencing Services, Microbial Genome-based Sequencing Services, Gene Regulation Services, Others)
  • 5.2.2. By Workflow (Pre-Sequencing, Sequencing, Data Analysis)
  • 5.2.3. By End User (Hospitals & Clinics, Academic & Research Institutions, Pharmaceutical & Biotechnology Companies, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Product Map
  • 5.3.1. By Service
  • 5.3.2. By Workflow
  • 5.3.3. By End User
  • 5.3.4. By Region

6. North America Next Generation Sequencing Services Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Service
  • 6.2.2. By Workflow
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Next Generation Sequencing Services Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Service
      • 6.3.1.2.2. By Workflow
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Next Generation Sequencing Services Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Service
      • 6.3.2.2.2. By Workflow
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Next Generation Sequencing Services Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Service
      • 6.3.3.2.2. By Workflow
      • 6.3.3.2.3. By End User

7. Europe Next Generation Sequencing Services Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Service
  • 7.2.2. By Workflow
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Next Generation Sequencing Services Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Service
      • 7.3.1.2.2. By Workflow
      • 7.3.1.2.3. By End User
  • 7.3.2. Germany Next Generation Sequencing Services Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Service
      • 7.3.2.2.2. By Workflow
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Next Generation Sequencing Services Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecasty
      • 7.3.3.2.1. By Service
      • 7.3.3.2.2. By Workflow
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Next Generation Sequencing Services Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Service
      • 7.3.4.2.2. By Workflow
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Next Generation Sequencing Services Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Service
      • 7.3.5.2.2. By Workflow
      • 7.3.5.2.3. By End User

8. Asia-Pacific Next Generation Sequencing Services Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Service
  • 8.2.2. By Workflow
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Next Generation Sequencing Services Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Service
      • 8.3.1.2.2. By Workflow
      • 8.3.1.2.3. By End User
  • 8.3.2. India Next Generation Sequencing Services Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Service
      • 8.3.2.2.2. By Workflow
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Next Generation Sequencing Services Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Service
      • 8.3.3.2.2. By Workflow
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Next Generation Sequencing Services Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Service
      • 8.3.4.2.2. By Workflow
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Next Generation Sequencing Services Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Service
      • 8.3.5.2.2. By Workflow
      • 8.3.5.2.3. By End User

9. South America Next Generation Sequencing Services Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Service
  • 9.2.2. By Workflow
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Next Generation Sequencing Services Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Service
      • 9.3.1.2.2. By Workflow
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Next Generation Sequencing Services Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Service
      • 9.3.2.2.2. By Workflow
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Next Generation Sequencing Services Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Service
      • 9.3.3.2.2. By Workflow
      • 9.3.3.2.3. By End User

10. Middle East and Africa Next Generation Sequencing Services Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Service
  • 10.2.2. By Workflow
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Next Generation Sequencing Services Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Service
      • 10.3.1.2.2. By Workflow
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Next Generation Sequencing Services Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Service
      • 10.3.2.2.2. By Workflow
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Next Generation Sequencing Services Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Service
      • 10.3.3.2.2. By Workflow
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global Next Generation Sequencing Services Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Quest Diagnostics Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Applied Biological Materials, Inc.
• 15.3. Novogene Co, Ltd.
• 15.4. Azenta Life Sciences (GENEWIZ)
• 15.5. NanoString Technologies, Inc.
• 15.6. Illumina, Inc.
• 15.7. PacBio, Inc.
• 15.8. Gene by Gene Ltd
• 15.9. Lucigen Corporation
• 15.10. ARUP Laboratories

16. Strategic Recommendations

17. About Us & Disclaimer